diabetes

Metabolic Syndrome in Men with Castration-Resistant Prostate Cancer Treated with Abiraterone Affects Their Survival

Yesterday’s post was about the increased risks of developing diabetes faced by men who are on hormone therapy. This study, as well as most others about this topic has looked at the first levels of hormone therapy (ADT) using the traditional drugs like Zoladex, Trelstar, Firmagon, and Lupron. We know very little about the influence [...]

By Malecare|2020-02-04T11:37:36-05:00July 10th, 2015|abiraterone acetate, Advanced Prostate Cancer, Firmagon (degarelix), prognostic tools, Quality of Life, Survival, Uncategorized, Zytiga|0 Comments

Hormone Therapy (ADT) Increases By 60% A Man’s Risk of Developing Diabetes

According to a recent study published in the Journal of Urology, men with localized prostate cancer on hormone therapy (ADT) have a significant increase in their risk for developing diabetes. In this retrospective study of 12,191 men with localized prostate cancer who did not have diabetes were followed once they went on ADT. It was [...]

By Malecare|2020-02-04T11:27:28-05:00July 9th, 2015|ADT, Advanced Prostate Cancer,